| Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc |
| Journal website https://jh.elmerpub.com |
Case Report
Volume 15, Number 3, June 2026, pages 162-168
Chronic Eosinophilic Leukemia Not Otherwise Specified: A Case Series
Figures




Tables
| 2020 (original consultation) | 2024 (second consultation) | 2024 (starting on TKI) | 2024 (1 month after TKI) | 2025 (3 months after TKI) | |
|---|---|---|---|---|---|
| TKI: tyrosine kinase inhibitor. | |||||
| White blood cell count | 18.1 × 103/µL | 32.3 × 103/µL | 19.5 × 103/µL | 24.8 × 103/µL | 26.0 × 103/µL |
| Absolute eosinophil count | 9.1 × 103/µL | 9.4 × 103/µL | 11.6 × 103/µL | 13.8 × 103/µL | 14.6 × 103/µL |
| Hemoglobin | 15.3 g/dL | 14.9 g/dL | 13.2 g/dL | 13.5 g/dL | 12.7 g/dL |
| Platelet count | 160 × 103/µL | 171 × 103/µL | 138 × 103/µL | 135 × 103/µL | 146 × 103/µL |
| 2017 (original consultation) | 2023 (CVA) | 2025 (atrial fibrillation diagnosis and stopped TKI) | 2025 (1 month after cessation of TKI) | 2025 (5 months after TKI) | |
|---|---|---|---|---|---|
| CVA: cerebrovascular accident; TKI: tyrosine kinase inhibitor. | |||||
| White blood cell count | 11.7 × 103/µL | 8.9 × 103/µL | 7.5 × 103/µL | 7.7 × 103/µL | 7.2 × 103/µL |
| Absolute eosinophil count | 0.1 × 103/µL | 0.1 × 103/µL | 0.2 × 103/µL | 0.2 × 103/µL | 0.2 × 103/µL |
| Hemoglobin | 17.1 | 16.4 | 17.3 | 18.5 | 16.5 |
| Platelet count | 173 | 172 | 167 | 164 | 160 |